洞察市场格局
解锁药品研发情报

免费客服电话

18983288589
试用企业版

首页 临床进展 Study on the risk perception, mental health, and behavioural responses of university students in Hong Kong in COVID-19 pandemic

【ChiCTR2000038864】Study on the risk perception, mental health, and behavioural responses of university students in Hong Kong in COVID-19 pandemic

查看原文
立即下载
基本信息
登记号

ChiCTR2000038864

试验状态

正在进行

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2020-10-07

临床申请受理号

/

靶点

/

适应症

新型冠状病毒肺炎(COVID-19)；心理衛生

试验通俗题目

Study on the risk perception, mental health, and behavioural responses of university students in Hong Kong in COVID-19 pandemic

试验专业题目

Study on the risk perception, mental health, and behavioural responses of university students in Hong Kong in COVID-19 pandemic

申办单位信息
申请人联系人
申请人名称
联系人邮箱
联系人邮编

联系人通讯地址
临床试验信息
试验目的

This study aims to evaluate the risk perception, mental health of university students in Hong Kong under COVID-19 pandemic. It will explore the interaction among risk perception, mental health, and behavioural responses, the differences in these 3 aspects among different faculties, and the reasons for these differences. It will provide an insight into how a pandemic can be better controlled in the future and allow appropriate support programmes and measures to be developed to help this target group.

试验分类
试验类型

连续入组

试验分期

其它

随机化

N/A

盲法

N/A

试验项目经费来源

N/A

试验范围

/

目标入组人数

600

实际入组人数

/

第一例入组时间

2020-10-19

试验终止时间

2022-12-31

是否属于一致性

/

入选标准

Undergraduate and postgraduate university students in Hong Kong, including students from different faculties and different universities.；

排除标准

Those who do not agree to participate.；

研究者信息
研究负责人姓名
试验机构

N/A

研究负责人电话
研究负责人邮箱
研究负责人邮编

/

联系人通讯地址
<END>

N/A的其他临床试验

更多

香港中文大學的其他临床试验

更多

最新临床资讯

更多
对摩熵医药数据库感兴趣，可以免费体验产品
体验产品